On the one hand, B cells can serve as positive mediators of the antitumour response through the production of tumour-reactive antibodies, promoting tumour killing by natural killer cells, phagocytosis by macrophages, and the priming of CD4+ and CD8+ cells [41]. This evidence concerns the gene CD8A and neoplasm.